| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.44 | 0.01 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |